ONCOCYTE

What this means for you

Registered since 27 Jul 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 27 Jul 2027, and its filing window is open now).

Record

Serial number

87429481

Registration number

6434765

Mark type

Word mark

Filed

28 Apr 2017

Published for opposition

12 Sept 2017

Registered

27 Jul 2021

Next maintenance filing

§8 declaration of use, due by 27 Jul 2027 (grace period to 27 Jan 2028)

Attorney of record

Christopher D. Olszyk, Jr.

Goods and services

• Class 042 — Scientific and technological services: Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
• Class 044 — Medical, beauty and agricultural services: Providing cancer screening services

Owner

• OncoCyte Corporation, Irvine, CA, US
• OncoCyte Corporation, Irvine, CA, US
• OncoCyte Corporation, Alameda, CA, US

Board proceedings on this mark

• Extension of Time to Oppose No. 87429481 — Genomic Health, Inc. v. OncoCyte Corporation, filed 10 Oct 2017 (Terminated)

Prosecution history

• 27 Jul 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 27 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
• 22 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 21 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 29 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
• 28 May 2021 — USE AMENDMENT FILED
• 28 May 2021 — TEAS STATEMENT OF USE RECEIVED
• 11 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 10 Dec 2020 — SOU EXTENSION 5 GRANTED
• 30 Nov 2020 — SOU EXTENSION 5 FILED
• 10 Dec 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 30 Nov 2020 — SOU TEAS EXTENSION RECEIVED
• 17 Jun 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 17 Jun 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 17 Jun 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED